Stallergenes Greer plc Notice of AGM
23 April 2018 - 4:00PM
UK Regulatory
TIDM0RB9
Notification to Stallergenes Greer Shareholders of Annual
General Meeting on 7 June 2018
The shareholders of Stallergenes Greer plc (Paris:STAGR), a
biopharmaceutical company specialising in treatments for
respiratory allergies, are hereby informed that they are invited to
attend the Company's Annual General Meeting at la Maison de la
Recherche, 54 rue de Varenne, 75007 Paris, France, on 7 June 2018
at 2:00p.m. (CET).
Notice of the meeting is available in the "Investors" section of
the Company website at www.stallergenesgreer.com. It contains the
draft resolutions proposed by the Board of Directors, the
explanatory notes and the main conditions under which shareholders
may participate, vote and exercise their rights.
All documents are at the disposal of shareholders, as part of
the Annual General Meeting, and are available at the registered
office of the Company in London (40 Bernard Street, 3rd Floor,
London WC1N 1LE, United Kingdom), in Antony (6 rue Alexis de
Tocqueville, 92160 Antony, France), and also in the "Investors"
section of the Company's website (www.stallergenesgreer.com), in
"Results & Presentations / Annual General Meeting / 2018".
ABOUT STALLERGENES GREER PLCHeadquartered in London (UK),
Stallergenes Greer plc is a global healthcare company specializing
in the diagnosis and treatment of allergies through the development
and commercialization of allergy immunotherapy products and
services. Stallergenes Greer plc is the parent company of GREER
Laboratories, Inc. (whose registered office is in the US) and
Stallergenes SAS (whose registered office is in France).
TRADING INFORMATIONName: Stallergenes GreerISIN: GB00BZ21RF93 1
- Ticker: STAGRICB Classification: 4577LEI:
213800CYVZA7GJQEME86Market: Euronext Paris regulated market
Additional information is available at
http://www.stallergenesgreer.com.
This document (including information incorporated by reference
in this document), oral statements made and other information
published by the Company contain statements that are or may be
forward-looking with respect to the financial condition and/or
results of operations and businesses of the Company. These
statements can be identified by the use of forward-looking
terminology such as "believe," "expects," "project," "estimated,"
"forecast," "should," "plan," "may" or the negative of any of
these, or other variations thereof, or comparable terminology
indicating expectations or beliefs concerning future events. These
forward-looking statements include risk and uncertainty because
they relate to events and depend on circumstances that will occur
in the future. Without being exhaustive, such factors include
economic situations and business conditions, including legal and
product evaluation issues, fluctuations in currencies and demand,
and changes in competitive factors. These and other factors are
more fully described in the Company's 2016 annual report published
on 28 April 2017 on the Company's website
www.stallergenesgreer.com. Actual results may differ from those set
forth in the forward-looking statements, due to various factors.
Save as required by applicable law, neither the Company nor any
other person assumes any obligation to update these forward-looking
statements or to notify any person of any such update.
Stallergenes Greer plcCommunications and Investor
RelationsNatacha Gassenbach, Tel: +1 (617) 225 8013Email:
natacha.gassenbach@stallergenesgreer.comorCaitlin Stefanik, Tel: +1
(857) 331 4117Email: caitlin.stefanik@stallergenesgreer.comorMedia
Relations AgencyHavas Paris (Europe)Samuel Rousseau, +33 6 77 88 32
43E-mail : samuel.rousseau@havas.comorInvestor Relations AgencyFTI
ConsultingArnaud de Cheffontaines, Tel: +33 1 47 03 68 10Email:
stalleregenesgreer@fticonsulting.com
View source version on businesswire.com:
https://www.businesswire.com/news/home/20180422005013/en/
This information is provided by Business Wire
(END) Dow Jones Newswires
April 23, 2018 02:00 ET (06:00 GMT)
Stallergenes Greer (LSE:0RB9)
Historical Stock Chart
From Apr 2024 to May 2024
Stallergenes Greer (LSE:0RB9)
Historical Stock Chart
From May 2023 to May 2024